CL 10-Q Quarterly Reports

Colgate-Palmolive Company (CL) reported a slight increase in net sales for the third quarter of 2025, reaching $5.131 billion, a 2.0% rise compared to the prior year's period. This growth was primarily driven by net selling price increases and a positive foreign exchange impact, though it was partially offset by a decline in sales volume. Diluted Earnings Per Share (EPS) saw a modest increase to $0.91 from $0.90 year-over-year. The company experienced higher raw and packaging material costs, which led to a decrease in gross profit margin. Despite this pressure, Colgate-Palmolive implemented cost-saving initiatives and pricing strategies to mitigate the impact. The company also announced a new "Strategic Growth and Productivity Program" aimed at driving future growth and efficiencies, which is expected to incur pre-tax charges between $200 and $300 million over the next three years. Management remains focused on driving organic sales growth and operational efficiencies despite challenging global macroeconomic conditions.

Colgate-Palmolive Company (CL) reported its financial results for the second quarter and first half of 2025. For the quarter, net sales increased by 1.0% to $5.11 billion, driven by net selling price increases, while volume remained flat. The Hill’s Pet Nutrition segment showed stronger growth at 3.8%, aided by the recent acquisition of Prime100. Diluted Earnings Per Share (EPS) saw an increase to $0.91 for the quarter. For the first six months, net sales saw a slight decrease of 1.0% to $10.02 billion, with organic sales growing 1.6% driven by price increases and a slight volume contribution from the Pet Nutrition segment. The company continues to manage through inflationary pressures and global economic uncertainties, implementing cost-saving initiatives and revenue growth management strategies.

Colgate-Palmolive Company reported first-quarter 2025 results with a slight decrease in net sales to $4.911 billion, down 3.1% from $5.065 billion in the prior year. This decline was primarily driven by a 4.4% negative impact from foreign exchange and a 0.1% volume decrease, partially offset by a 1.5% increase in net selling prices. On an organic basis (excluding foreign exchange, acquisitions, and divestitures), net sales grew by 1.4%. Diluted earnings per share increased to $0.85 from $0.83 in the prior year, showing a positive trend despite top-line pressure. The company experienced mixed performance across its segments, with Oral, Personal, and Home Care net sales decreasing 4.3% (though organic sales grew 1.0%), while Hill's Pet Nutrition saw a 1.5% increase in net sales (with organic sales up 2.9%). The company highlighted improvements in gross profit margin to 60.8% from 60.0%, driven by cost savings, pricing actions, and favorable mix, which helped to offset increased raw and packaging material costs. Management indicated continued focus on organic sales growth, operational efficiencies, and capital allocation, including increased dividends and a new share repurchase program.

Colgate-Palmolive Company reported solid financial results for the nine months ended September 30, 2024, with net sales increasing by 4.5% to $15.2 billion and net income attributable to the company rising 36% to $2.15 billion. Diluted EPS also saw a significant increase to $2.61 from $1.90 in the prior year period. The company demonstrated strong organic sales growth of 8.5% for the nine-month period, driven by both volume and pricing strategies across its Oral, Personal and Home Care, and Pet Nutrition segments. Gross profit margin improved to 60.6% from 57.7% in the prior year, reflecting cost savings and pricing actions, though partially offset by higher raw material costs. The company continues to navigate a challenging macroeconomic environment characterized by inflation and foreign currency volatility, particularly in hyper-inflationary economies. Despite these headwinds, Colgate-Palmolive maintained its market share in global toothpaste and manual toothbrush categories. The company's strategic focus on innovation, efficiency through its "funding-the-growth" initiatives, and investment in brands positions it for continued resilience and growth, even amidst global economic uncertainties and increased competition.

Colgate-Palmolive Company (CL) reported robust financial results for the second quarter and first half of 2024, demonstrating strong top-line growth driven by both volume and pricing. For the three months ended June 30, 2024, Net sales increased by 4.9% to $5,058 million, and organic sales grew by 9.0%. This growth was supported by solid performance in both the Oral, Personal and Home Care segment and the Pet Nutrition segment (Hill's Pet Nutrition). Diluted Earnings Per Share (EPS) reached $0.89, a significant increase from $0.60 in the prior year period. The company also saw an improvement in Gross profit margin to 60.6% and Operating profit margin to 21.6%, reflecting successful cost-saving initiatives and pricing strategies. The first half of 2024 also showed positive momentum with Net sales up 5.5% to $10,124 million and organic sales up 9.4%. Diluted EPS for the six months ended June 30, 2024, was $1.71, up from $1.05 in the prior year. The company continues to invest in brand building and innovation, as evidenced by increased advertising spend, positioning it for continued growth in a challenging global economic environment.

Colgate-Palmolive Company reported robust financial results for the first quarter of 2024, demonstrating strong top-line growth and improved profitability. Net sales increased by 6.2% year-over-year, driven by both volume growth and significant price increases, with organic sales growing by 9.8%. This growth was broad-based across its core Oral, Personal and Home Care segment and the Pet Nutrition segment. The company also showcased enhanced profitability, with gross profit margin expanding to 60.0% from 56.9% in the prior year, attributed to higher pricing and cost savings initiatives. Operating profit saw a substantial 15% increase, reflecting improved operational efficiencies and strategic pricing actions. Diluted Earnings Per Share (EPS) rose to $0.83, up significantly from $0.45 in the first quarter of 2023, highlighting the company's ability to translate sales growth into enhanced shareholder returns. The company also announced an increase in its quarterly common stock dividend, signaling confidence in its financial health and commitment to returning value to shareholders.

Colgate-Palmolive Company reported strong top-line growth in the third quarter of 2023, with Net sales increasing by 10.5% to $4.915 billion compared to the prior year period. This growth was driven by a significant 9.5% increase in net selling prices and a modest 0.5% volume increase, alongside a slight positive foreign exchange impact. The company's organic sales, a key non-GAAP metric excluding currency fluctuations and acquisitions, grew by 9.0%. Profitability also saw improvement, with operating profit increasing by 9% to $1.029 billion. Diluted Earnings Per Share (EPS) rose to $0.86, a notable increase from $0.74 in the prior year quarter. Despite ongoing inflationary pressures on raw materials, the company managed to expand its Gross Profit margin to 58.5% due to strategic pricing actions and cost-saving initiatives, though this was partially offset by higher input costs. The Pet Nutrition segment, driven by Hill's Pet Nutrition, showed particularly strong performance with a 21.5% increase in net sales.

Colgate-Palmolive Company reported solid top-line growth in the second quarter of 2023, with Net sales increasing by 7.5% to $4.82 billion compared to the prior year. This growth was primarily driven by net selling price increases of 11.0%, though partially offset by a 1.5% decline in volume. Organic sales, excluding foreign exchange and acquisitions, rose by 8.0%. The Pet Nutrition segment, particularly Hill's Pet Nutrition, showed strong performance with a 16.0% increase in Net sales, fueled by both volume and pricing. Despite revenue growth, the company faced a significant increase in its effective income tax rate to 39.8% due to a $148 million discrete tax charge related to reassessed prior-year tax deductions. This, along with other ongoing charges, led to a decrease in net income attributable to Colgate-Palmolive Company to $502 million ($0.60 diluted EPS) from $603 million ($0.72 diluted EPS) in the prior year. Excluding certain discrete items, adjusted net income increased by 6% and adjusted diluted EPS rose by 7%, indicating underlying operational strength despite the tax impact.

Colgate-Palmolive Company reported its first-quarter 2023 financial results, showing a notable increase in net sales, driven primarily by price increases across its product segments. While top-line growth was strong, net income and earnings per share saw a decline compared to the prior year, largely due to significant one-time charges, including a substantial accrual for an ERISA litigation matter and product recall costs. The company's Oral, Personal, and Home Care segment experienced moderate sales growth, while the Pet Nutrition segment, particularly Hill's Pet Nutrition, demonstrated robust growth in both sales and volume. Despite inflationary pressures impacting gross margins, Colgate-Palmolive is strategically managing costs and continuing to invest in advertising and innovation to support its brands and drive long-term growth.

Colgate-Palmolive Company reported mixed financial results for the third quarter ended September 30, 2022. While net sales saw a slight increase of 1.0% to $4,455 million, this was primarily driven by price increases (11.5%) rather than volume growth, which declined by 4.5%. Organic sales, excluding foreign exchange, acquisitions, and divestitures, grew by a more robust 7.0%. However, profitability faced pressure, with Gross Profit declining due to significant increases in raw and packaging material costs (920 bps), partially offset by pricing and cost savings initiatives. Diluted Earnings Per Share (EPS) decreased to $0.74 from $0.75 in the prior year's quarter. The company also completed a significant acquisition in its Pet Nutrition segment, acquiring Red Collar Pet Foods for $727 million to support the growth of its Hill's Pet Nutrition business. Management highlighted ongoing challenges from global macroeconomic conditions, inflation, rising interest rates, and supply chain disruptions, while also noting efforts to mitigate these through pricing and productivity initiatives.

Colgate-Palmolive Company's Q2 2022 filing shows a 5.5% increase in net sales to $4.484 billion, driven by a 0.5% volume increase and 8.5% price hikes, with organic sales up 9.0%. The Oral, Personal, and Home Care segment saw a 3.0% sales increase, while Hill's Pet Nutrition reported a strong 14.5% sales jump. However, gross profit margin declined by 300 basis points to 57.0% due to significantly higher raw and packaging material costs, which outpaced pricing and cost savings. Diluted EPS decreased to $0.72 from $0.83 in the prior year's comparable quarter, reflecting these cost pressures and the impact of the 2022 Global Productivity Initiative. The company is navigating a challenging macroeconomic environment characterized by inflation, increased logistics costs, and supply chain disruptions, further exacerbated by the war in Ukraine and ongoing COVID-19 impacts. Despite these headwinds, Colgate-Palmolive is focused on strategic pricing, cost efficiencies through its productivity initiatives, and investing in brand support and digital capabilities to drive long-term growth and shareholder value.

Colgate-Palmolive Company (CL) reported first-quarter 2022 results showing a slight increase in net sales to $4,399 million, up 1.5% year-over-year. This growth was primarily driven by a 5.5% increase in net selling prices, which more than offset a 1.5% decline in volume and a 2.5% negative impact from foreign exchange. The company's organic sales, excluding currency fluctuations, increased by 4.0%, highlighting resilient underlying demand. Despite top-line growth, operating profit saw a significant decline of 14% to $860 million, impacted by a 220 basis point decrease in gross profit margin to 58.5%. This margin compression was largely attributed to a substantial rise in raw and packaging material costs, which added 590 basis points, though partially mitigated by pricing actions and cost savings initiatives. Diluted earnings per share decreased to $0.66 from $0.80 in the prior year, reflecting these cost pressures and the impact of the new 2022 Global Productivity Initiative charges.

Colgate-Palmolive Company (CL) reported its third-quarter and year-to-date results for the period ending September 30, 2021. For the third quarter, net sales increased by 6.5% year-over-year, driven by volume growth, price increases, and favorable foreign exchange. Organic sales, excluding these factors, grew by 4.5%. The Pet Nutrition segment, particularly Hill's Pet Nutrition, showed robust growth of 20.0% in net sales, a significant contributor to the overall increase. Despite top-line growth, profitability faced pressure. Gross profit margin declined by 180 basis points due to higher raw and packaging material costs, which were partially offset by cost savings and pricing initiatives. Selling, general, and administrative expenses also increased as a percentage of net sales, largely due to higher logistics costs. Consequently, operating profit margin decreased by 260 basis points year-over-year. Diluted earnings per share (EPS) for the quarter were $0.75, down from $0.81 in the prior year, though adjusted EPS showed a modest increase.

Colgate-Palmolive Company reported solid performance for the second quarter and first half of 2021, demonstrating revenue growth driven by a combination of volume, pricing, and favorable foreign exchange rates. The company experienced a 9.5% increase in net sales for the quarter, reaching $4.26 billion, with organic sales up 5.0%. This growth was particularly strong in the Pet Nutrition segment, which saw an 18.0% increase in net sales. However, gross profit margin faced pressure, decreasing to 60.0% from 60.8% year-over-year, primarily due to significantly higher raw and packaging material costs, partially offset by cost savings initiatives and increased pricing. Despite margin headwinds, the company saw an increase in diluted earnings per share to $0.83 for the quarter, up from $0.74 in the prior year, reflecting effective management of expenses and a favorable tax impact. Geographically, Latin America and Africa/Eurasia showed robust organic sales growth, while North America experienced a slight decline. The company continues to navigate a challenging cost environment and heightened competition, but remains focused on its strategic priorities of innovation, brand building, and expansion in high-growth channels.

Colgate-Palmolive Company reported first-quarter 2021 results showing a 6.0% increase in net sales to $4.344 billion, driven by a 4.5% increase in net selling prices and a 1.0% positive foreign exchange impact. Organic sales grew by 5.0%. The Oral, Personal, and Home Care segment saw a 5.5% increase in net sales, while Hill's Pet Nutrition experienced a 9.5% rise. Despite top-line growth, diluted earnings per share decreased slightly to $0.80 from $0.83 in the prior year period, primarily due to increased selling, general, and administrative expenses, including higher advertising investment and overhead costs, as well as elevated raw and packaging material costs impacting gross margins. The company continues to focus on its "funding-the-growth" initiatives to drive efficiency and cost savings, which partially offset inflationary pressures. Management expressed confidence in the company's financial position and strategy to navigate ongoing challenges, including economic uncertainties and competitive pressures, while continuing to invest in innovation, e-commerce, and sustainability. The company also saw a moderation in share repurchases compared to prior periods but indicated a return to historical levels in Q1 2021.

Colgate-Palmolive Co. (CL) reported strong third-quarter 2020 results, with Net Sales increasing by 5.5% year-over-year to $4.15 billion, driven by a 5.0% volume increase and a 4.5% net selling price increase. Organic sales, a key metric excluding currency fluctuations and acquisitions, grew by a robust 7.5%. This growth was broad-based across its segments, with notable strength in Hill's Pet Nutrition (up 11.0%) and positive organic sales growth in Oral, Personal, and Home Care. Diluted Earnings Per Share (EPS) rose to $0.81, up from $0.67 in the prior year quarter, reflecting improved profitability. The company also managed its expenses effectively, with Gross Profit margin improving significantly, showcasing its ability to pass on increased costs through pricing while benefiting from cost-saving initiatives. The company highlighted resilience amidst the ongoing COVID-19 pandemic, noting that many of its products were deemed essential. While some channels like professional sales and travel retail saw declines, increased demand was observed in categories such as liquid hand soap and cleaners, with some of this growth expected to be sustainable. Management reiterated its commitment to driving growth through innovation, expanding online channels, and maintaining a disciplined capital allocation strategy, including a moderate share repurchase program and a recent dividend increase. The company's financial position remains solid, with sufficient operating cash flow and access to credit markets to meet its obligations.

Colgate-Palmolive Company (CL) reported solid financial results for the second quarter and first half of 2020, demonstrating resilience amidst the COVID-19 pandemic. Net sales saw a modest increase of 1.0% for the quarter and 3.0% for the six-month period, with organic sales growing by 5.5% and 6.5% respectively, indicating underlying business strength. Profitability also improved, with operating profit up 7% for the quarter and 7% for the six months. Diluted earnings per share rose to $0.74 for the quarter and $1.57 for the six months, up from $0.68 and $1.33 in the prior year periods. The company successfully managed gross profit margins, which improved due to cost savings initiatives and higher pricing, despite increased raw material costs. Colgate-Palmolive also strategically increased its advertising investment to support brand building. The company benefited from increased demand for certain essential hygiene and cleaning products due to the pandemic, while its Pet Nutrition segment, particularly Hill's Pet Nutrition, showed strong growth. Management remains focused on innovation, efficiency, and disciplined capital allocation to drive long-term shareholder value, while navigating the ongoing uncertainties posed by the global pandemic.

Colgate-Palmolive Company reported strong first-quarter 2020 results, with net sales increasing by 5.5% to $4.1 billion, driven by a 7.5% organic sales growth. This performance was significantly boosted by increased demand for health and hygiene products amidst the COVID-19 pandemic, which offset some of the challenges posed by the global health crisis. Diluted earnings per share rose to $0.83, a notable increase from $0.65 in the prior year's quarter, reflecting improved profitability and effective cost management. The company demonstrated resilience and adaptability in navigating the complexities of the pandemic, maintaining operations for essential products and prioritizing employee safety. Strategic acquisitions, such as Hello Products LLC, further supported growth. While the outlook presents ongoing challenges due to economic uncertainty and heightened competition, Colgate-Palmolive remains focused on innovation, efficiency, and strong cash flow generation to drive long-term shareholder value.

Colgate-Palmolive Co. reported net sales of $3,928 million for the third quarter of 2019, a 2.0% increase year-over-year, driven by volume growth and net selling price increases, partially offset by unfavorable foreign exchange. Organic sales, excluding these impacts, grew by 4.5%. For the nine-month period, net sales slightly decreased by 0.5% to $11,678 million, with organic sales growing 3.5%. The company successfully completed the acquisition of Laboratoires Filorga Cosmétiques (Filorga) for approximately $1.7 billion, bolstering its premium skin health portfolio. Profitability showed mixed results. While gross profit increased slightly for the quarter, operating profit saw a modest decrease due to increased selling, general, and administrative expenses, particularly higher advertising investment. Net income attributable to Colgate-Palmolive Company rose to $578 million from $523 million in the prior year quarter, with diluted EPS increasing to $0.67 from $0.60. The company continues to manage costs through its Global Growth and Efficiency Program, which is expected to achieve significant annual savings upon completion.

Colgate-Palmolive Company reported its financial results for the second quarter and first half of 2019. For the second quarter, net sales saw a slight decrease of 0.5% year-over-year to $3.866 billion, with organic sales growing 4.0%. Diluted earnings per share (EPS) decreased to $0.68 from $0.73 in the prior year period. The decrease in EPS was influenced by higher selling, general, and administrative expenses, partly due to increased advertising investment and overhead costs, as well as ongoing restructuring charges from the "Global Growth and Efficiency Program". For the first half of 2019, net sales decreased by 2.0% to $7.750 billion, with organic sales growing 3.5%. Diluted EPS for the first half also declined to $1.33 from $1.45 in the same period last year. The company continues to focus on its core segments: Oral, Personal and Home Care, and Pet Nutrition. A significant event announced post-quarter was the agreement to acquire the skin care business "Laboratoires Filorga Cosmétiques" for approximately $1.690 billion, expected to close in the third quarter of 2019. The company reaffirmed its commitment to driving efficiency, innovation, and shareholder returns.

Colgate-Palmolive Company's first quarter 2019 results, filed on April 25, 2019, showed a slight decrease in net sales to $3.88 billion from $4.00 billion in the prior year's quarter, largely due to unfavorable foreign exchange impacts. Despite this, organic sales grew by 3.0%, driven by a 1.0% volume increase and a 2.0% rise in net selling prices, indicating underlying business strength. Net income attributable to Colgate-Palmolive Company declined to $560 million ($0.65 per diluted share) from $634 million ($0.72 per diluted share) in the first quarter of 2018. This decline was influenced by higher raw and packaging material costs and increased advertising investment, partially offset by cost savings initiatives and a slight decrease in selling, general and administrative expenses. The company continues to execute its Global Growth and Efficiency Program, which is in its final year and aims to streamline operations and reduce costs.

Colgate-Palmolive Company's (CL) third-quarter and year-to-date 2018 results show a mixed performance for investors. While the company reported slight year-over-year increases in net sales and net income attributable to Colgate-Palmolive Company for the nine-month period, the third quarter itself saw a decline in net sales and operating profit. This performance was impacted by negative foreign exchange rates and increased raw and packaging material costs, which pressured gross profit margins. Despite these headwinds, the company continues to execute its "Global Growth and Efficiency Program," aiming to streamline operations and drive long-term growth. The acquisition of professional skin care businesses also contributed to volume growth in North America. Investors should note the ongoing restructuring charges and the impact of U.S. tax reform, which influenced effective tax rates and net income. The company maintains a positive outlook, focusing on innovation, efficiency, and cash flow generation to enhance shareholder value.

Colgate-Palmolive Company reported solid financial results for the second quarter and the first six months of 2018, demonstrating resilience in a challenging global economic environment. The company saw an increase in net sales driven by volume growth, particularly in its core Oral, Personal, and Home Care segments, alongside contributions from its Pet Nutrition division. Despite facing headwinds such as rising raw material costs and foreign exchange volatility, Colgate-Palmolive maintained a focus on cost efficiencies and strategic growth initiatives, including the Global Growth and Efficiency Program, which aims to streamline operations and drive future savings. Diluted earnings per share saw a significant increase compared to the prior year, supported by improved operational performance and a favorable tax rate following the Tax Cuts and Jobs Act (TCJA). The company also continued its commitment to shareholder returns through dividend payments and share repurchases, underscoring its financial strength and commitment to creating long-term value for its investors.

Colgate-Palmolive Company reported a strong first quarter for 2018, with net sales increasing by 6.5% to $4,002 million compared to the prior year. This growth was driven by a combination of volume increases (2.0%), positive foreign exchange impacts (4.5%), and a modest contribution from recent acquisitions in the professional skin care category. Organic sales, which exclude foreign exchange and acquisition impacts, grew by 1.5%, indicating underlying business momentum. Profitability also showed improvement, with operating profit rising 8% to $983 million. Diluted earnings per share increased to $0.72 from $0.64 in the prior year. The company continues to execute its "Global Growth and Efficiency Program," which aims to streamline operations and reduce costs, contributing to efficiency gains despite increased raw material costs. Management remains focused on driving innovation, expanding market leadership, and managing costs to deliver long-term shareholder value in a challenging global economic environment.

Colgate-Palmolive Co. reported financial results for the third quarter and first nine months of 2017. For the three months ended September 30, 2017, net sales increased by 3.0% to $3,974 million, driven by a 1.5% volume increase and 1.5% positive foreign exchange impact, while net selling prices remained flat. Organic sales grew by 1.5%. Diluted Earnings Per Share (EPS) decreased to $0.68 compared to $0.78 in the prior year quarter. For the nine months ended September 30, 2017, net sales grew by 1.0% to $11,562 million, with volume declining slightly by 0.5% but offset by net selling price increases of 1.0% and positive foreign exchange of 0.5%. Organic sales increased by 0.5%. Diluted EPS for the nine-month period decreased to $1.91 from $2.04 in the prior year. The company is actively managing its "Global Growth and Efficiency Program," which involves restructuring initiatives aimed at streamlining operations and reducing costs, with an extended timeline through December 31, 2019.

Colgate-Palmolive Co. (CL) reported its second-quarter and year-to-date financial results for the period ending June 30, 2017. For the quarter, net sales were $3.83 billion, a slight decrease of 0.5% compared to the prior year, with organic sales remaining flat. Diluted EPS for the quarter was $0.59, down from $0.67 in the same period last year. For the first six months of the year, net sales were $7.59 billion, a marginal decrease of 0.25%, and organic sales were flat. Diluted EPS for the six-month period was $1.23, down from $1.26 in the prior year. The company continued to navigate challenging market conditions with slow category growth and increased competition. The 2012 Restructuring Program remains a key focus, with updated estimates for charges and savings. Despite mixed sales performance across segments and geographies, the company emphasized its strong financial position and strategic initiatives aimed at driving long-term shareholder value. Investments in advertising and innovation were noted, alongside efforts to improve efficiency and reduce costs.

Colgate-Palmolive Company reported stable net sales of $3,762 million for the first quarter of 2017, matching the prior year's first quarter. This was achieved through a delicate balance of a 2.5% increase in net selling prices, which was fully offset by a 2.0% decline in volume and a 0.5% negative foreign exchange impact. Organic sales, excluding foreign exchange, acquisitions, and divestments, showed a modest increase of 0.5% year-over-year. Net income attributable to Colgate-Palmolive Company rose to $570 million from $533 million in the prior year's quarter, leading to a diluted Earnings Per Share (EPS) increase to $0.64 from $0.59. This improvement was bolstered by a higher gross profit margin, driven by cost savings initiatives and pricing, despite increased raw and packaging material costs. The company continued to execute its 2012 Restructuring Program, which is expected to yield significant long-term savings and operational efficiencies.

Colgate-Palmolive Company's third-quarter 2016 report shows a slight decrease in net sales, primarily due to volume declines and negative foreign exchange impacts, despite a 3.0% increase in net selling prices. However, the company demonstrated resilience through a 4.5% increase in organic sales, excluding currency fluctuations and other adjustments, indicating underlying business strength. Profitability saw an improvement in gross profit margin, driven by cost savings initiatives and higher pricing, which helped offset increased raw material costs and the impact of the Venezuelan operations deconsolidation. While operating profit saw a GAAP decrease, adjusted figures show a slight increase, reflecting effective cost management. The company continues to execute its "Global Growth and Efficiency Program," impacting current expenses but aiming for long-term savings. Diluted earnings per share experienced a slight decline on a GAAP basis, though adjusted figures showed a modest increase, reflecting the company's ability to navigate a challenging global economic environment.

Colgate-Palmolive Company's Q2 2016 report shows a slight decrease in net sales, primarily due to unfavorable foreign exchange rates and volume declines, partially offset by price increases. Despite these top-line pressures, the company demonstrated resilience in its profitability, with an increase in gross profit margin driven by effective cost savings initiatives and strategic pricing. The Pet Nutrition segment showed consistent growth. Management remains focused on cost optimization and innovation as key drivers for future growth amidst a challenging global economic environment. Key financial developments include a significant increase in net cash provided by operations, indicating strong operational cash generation. The company also continued its restructuring efforts under the 2012 Global Growth and Efficiency Program, which is expected to yield substantial long-term savings. While sales faced headwinds, the company maintained a strong balance sheet and liquidity position, supported by consistent dividend payments and share repurchases.

Colgate-Palmolive Company's first quarter 2016 results show a decrease in net sales by 7.5% to $3,762 million compared to the prior year's $4,070 million. This decline was primarily attributed to a volume decrease of 1.0% and negative foreign exchange impacts of 8.0%, partially offset by a 1.5% increase in net selling prices. However, excluding the deconsolidation of its Venezuelan operations and divestitures, the company reported a positive organic sales growth of 5.0%. Net income attributable to Colgate-Palmolive Company decreased to $533 million from $542 million in the prior year, resulting in diluted earnings per share remaining flat at $0.59. Despite the top-line decline, the company achieved an improved gross profit margin of 59.8% (60.0% excluding restructuring charges) due to cost savings initiatives and higher pricing, which helped offset increased raw material costs. The company is actively engaged in a "2012 Restructuring Program" aimed at enhancing efficiency and long-term growth, with expanded initiatives now extending through December 31, 2017. This program is expected to incur significant charges but generate substantial annual savings. While global market conditions remain challenging, Colgate-Palmolive emphasizes its strong brand portfolio, global presence, and focus on strategic initiatives to drive shareholder value.

Colgate-Palmolive Company reported its financial results for the third quarter and the first nine months of 2015. For the three months ended September 30, 2015, net sales decreased by 8.5% to $3,999 million compared to the prior year, primarily driven by unfavorable foreign exchange rates (-13.0%), though this was partially offset by organic sales growth of 5.0% (volume +1.0%, pricing +3.5%). Diluted earnings per share (EPS) rose to $0.80, a significant increase from $0.59 in the same period last year, benefiting from factors like a gain on the sale of a South Pacific business and lower restructuring charges year-over-year. For the nine months ended September 30, 2015, net sales declined by 7.0% to $12,135 million, also impacted by foreign exchange, but organic sales grew by 5.0%. Diluted EPS for the nine-month period increased to $2.02, up from $1.68 in the prior year. The company continues to execute its 2012 Restructuring Program, which aims to drive efficiency and cost savings, and has expanded this program. Management highlights the ongoing challenges posed by macroeconomic conditions, particularly in Venezuela, due to currency devaluation, inflation, and governmental restrictions, which significantly impacted results in the current period. Despite these challenges, the company demonstrates resilience through organic growth in its core segments and strategic initiatives aimed at long-term shareholder value.

Colgate-Palmolive Company's Q2 2015 10-Q filing indicates a challenging quarter marked by a 6.5% decrease in net sales year-over-year, primarily due to a significant negative impact from foreign exchange (12.0%). Despite this top-line decline, the company demonstrated resilience with a 5.5% increase in organic sales, driven by volume growth of 3.0% and a 2.5% increase in net selling prices. This organic growth was present across both the Oral, Personal and Home Care segment and the Pet Nutrition segment, suggesting underlying brand strength. Profitability was impacted by various factors, including restructuring charges associated with the 2012 Global Growth and Efficiency Program and significant foreign currency remeasurement losses in Venezuela. Nevertheless, the company maintained a strong operating profit margin of 22.9%. Colgate-Palmolive also continued its commitment to shareholder returns through a 6% increase in its annualized dividend and active share repurchases. The company's financial position remains solid, with sufficient liquidity expected from operations and debt issuances to cover its foreseeable needs.

Colgate-Palmolive Company's first quarter 2015 results showed a year-over-year decline in net sales, primarily driven by unfavorable foreign currency exchange rates, which significantly impacted reported figures. Despite the top-line decrease, the company demonstrated resilience with a notable increase in operating profit and net income, largely due to effective cost management and a substantial improvement in gross profit margin. The company's "funding-the-growth" initiatives and restructuring programs are showing positive impacts on profitability. While overall sales were down, organic sales, which exclude currency fluctuations, showed positive growth across most segments, indicating underlying demand for Colgate's products. The company continues to manage its operations effectively in challenging global economic conditions, with a focus on innovation, cost efficiencies, and strategic market leadership. Investors should note the continued impact of foreign exchange and the company's ongoing restructuring efforts as key factors influencing reported financial performance.

Colgate-Palmolive Company's (CL) third-quarter 2014 results show a slight decline in net sales, primarily due to unfavorable foreign exchange rates, despite positive volume growth and pricing increases. Net sales for the quarter were $4,379 million, a 0.5% decrease year-over-year. Diluted earnings per share (EPS) also saw a decrease, falling to $0.59 from $0.70 in the prior year's comparable quarter. This decline was impacted by significant charges, including a $66 million charge related to a foreign tax matter, Venezuela remeasurement losses totaling $61 million, and costs associated with the ongoing 2012 Restructuring Program. Despite these headwinds, the company demonstrated resilience in its core business. Organic sales, which exclude foreign exchange impacts, increased by 3.5% globally, indicating underlying demand for its products. The Oral, Personal and Home Care segment, as well as the Pet Nutrition segment, both showed positive organic sales growth. The company also continues to execute its long-term strategies, including expanding its restructuring program to drive efficiency and cost savings, which are expected to yield significant benefits in the future. Investors should note the substantial impact of currency fluctuations and the specific challenges in markets like Venezuela, which are affecting reported financial results.

Colgate-Palmolive Company's second quarter of 2014 reported flat net sales compared to the prior year, reaching $4,352 million. This stability was achieved despite a 4.0% negative impact from foreign exchange, as volume growth of 2.5% and a 1.5% increase in net selling prices helped offset this headwind. The company's organic sales, which exclude currency fluctuations, grew by a healthy 4.0%. Diluted earnings per share (EPS) increased to $0.67 from $0.60 in the prior year's second quarter, reflecting improved operational efficiencies and a favorable tax rate. The company continues to navigate challenging global macroeconomic conditions, including volatile foreign currency exchange rates and increased competition. Significant efforts are underway through the '2012 Restructuring Program' to drive efficiency and cost savings, which contributed positively to gross profit margin. The company also highlighted the significant impact of the Venezuelan economic situation, including currency devaluation and new foreign exchange regulations, which resulted in a substantial pretax loss in the first quarter of 2014. Despite these challenges, Colgate-Palmolive remains focused on its core strategies of brand building, innovation, and operational efficiency to drive long-term shareholder value.

Colgate-Palmolive Company's first quarter of 2014 reported flat net sales of $4.325 billion, mirroring the previous year's results. This stability was achieved despite a 6.5% negative foreign exchange impact, with organic sales increasing by 6.5% driven by volume growth and price increases. The company saw a decrease in net income attributable to Colgate-Palmolive Company to $388 million from $460 million in the prior year, resulting in diluted EPS of $0.42 compared to $0.48. This decline was significantly influenced by a $266 million pretax charge related to the remeasurement of Venezuelan operations due to currency devaluation, alongside restructuring charges. Despite the reported net income decrease, the company's operational performance remained robust with strong organic sales growth across key segments. The company highlighted its focus on "funding-the-growth" initiatives to drive efficiency and cost savings. Key financial actions included increased debt issuance to manage liquidity and strategic capital expenditures. The company maintains a positive outlook, emphasizing its global brand strength and strategic initiatives to drive long-term shareholder value, while acknowledging ongoing challenges in macroeconomic conditions and foreign currency fluctuations.

Colgate-Palmolive Company reported net sales of $4,398 million for the third quarter of 2013, a 1.5% increase over the prior year, driven by a 5.0% volume increase, partially offset by a 4.5% negative foreign exchange impact. Organic sales, excluding foreign exchange and acquisitions/divestitures, grew a healthy 6.0%. Net income attributable to the company was $656 million, with diluted EPS of $0.70, a slight increase from $0.69 in the prior year period. The company is actively managing a global restructuring program initiated in 2012, which is expected to yield significant cost savings over the next few years, though it incurred charges in the current quarter. Investments in advertising and promotional activities remain a key focus to drive brand growth.

Colgate-Palmolive Company's (CL) Q2 2013 filing shows a modest increase in net sales, driven by volume growth, though impacted by negative foreign exchange. The company is executing a significant Global Growth and Efficiency Program, which incurred substantial restructuring charges impacting operating profit and net income. Despite these headwinds, the company demonstrated resilience in organic sales growth across key segments, particularly in emerging markets. Key financial highlights include a continued focus on cost savings initiatives and capital allocation through dividends and share repurchases, while managing complex international operations, notably the ongoing challenges in Venezuela due to currency devaluation and economic instability. Investors should note the company's strategic emphasis on core product categories and geographic diversity to mitigate risks. The increase in selling, general, and administrative expenses, particularly advertising investment, alongside ongoing restructuring costs, are key areas to monitor. While GAAP net income and EPS saw a decline compared to the prior year, the company emphasizes its non-GAAP performance which shows growth, reflecting operational improvements outside of significant one-time charges.

Colgate-Palmolive Company reported first-quarter 2013 results showing a modest increase in net sales, driven by volume growth, though this was partially offset by negative foreign exchange impacts. The company faced significant headwinds, most notably a one-time charge of $172 million due to the devaluation of the Venezuelan bolivar, which materially impacted net income and earnings per share. Despite these challenges, the company is progressing with its 'Global Growth and Efficiency Program,' initiated in late 2012, which involves substantial restructuring charges but is expected to yield significant long-term savings and efficiency gains. While overall profitability declined year-over-year on a reported basis, management highlights that on a non-GAAP basis, excluding the Venezuela devaluation charge and restructuring costs, net income and earnings per share actually increased, indicating underlying operational strength. The company's strategic focus remains on its core Oral, Personal, and Home Care, and Pet Nutrition segments, with a strong emphasis on innovation and market leadership in emerging markets. Colgate-Palmolive also announced a two-for-one stock split, signaling confidence in future performance and aiming to increase shareholder accessibility.

Colgate-Palmolive Co. reported its third-quarter and nine-month results for the period ending September 30, 2012. For the third quarter, net sales saw a slight decrease of 1.0% year-over-year, primarily due to unfavorable foreign exchange rates, although organic sales (excluding FX, acquisitions, and divestitures) grew by 5.0%. Diluted earnings per share (EPS) increased to $1.36 from $1.31 in the prior year's third quarter. For the nine-month period, net sales increased by 2.0%, with organic sales growing by 6.5%. Diluted EPS for the nine months rose to $3.89 from $3.73 in the comparable period of 2011. The company highlighted strong performance in the Greater Asia/Africa region and Pet Nutrition segment, while Europe/South Pacific experienced a decline in net sales. A significant new initiative, the "Global Growth and Efficiency Program," was announced, expecting substantial restructuring charges and future cost savings. The company also noted ongoing challenges related to global macroeconomic conditions, competition, and currency fluctuations, particularly in Venezuela.

Colgate-Palmolive Company reported solid financial results for the second quarter and first half of 2012. For the three months ended June 30, 2012, net sales increased by 2.0% to $4,267 million, and diluted earnings per share (EPS) rose to $1.30 from $1.26 in the prior year quarter. For the six-month period, net sales grew 3.5% to $8,467 million, and diluted EPS increased to $2.53 from $2.42. The company saw positive organic sales growth driven by volume and pricing, despite negative foreign exchange impacts. Key operational highlights include strong performance in emerging markets, particularly Latin America, which experienced robust organic sales growth. The company continued to focus on its 'funding-the-growth' initiatives to drive cost savings and efficiency, which contributed to improved gross profit margins. However, the company faces challenges including volatile foreign currency fluctuations, rising commodity costs, and increased competition. Management remains confident in its strategic initiatives and financial strength to navigate these challenges and deliver long-term shareholder value.

Colgate-Palmolive Company reported a solid first quarter for 2012, with net sales increasing by 5.0% to $4.2 billion compared to the same period in 2011. This growth was driven by a combination of volume increases and strategic pricing, partially offset by unfavorable foreign exchange rates. Diluted earnings per share also saw a healthy increase to $1.23, up from $1.16 in the prior year, indicating improved profitability. The company's core Oral, Personal, and Home Care segment performed well, with notable growth in Latin America and Greater Asia/Africa. The acquisition of the Sanex business continued to contribute positively to sales. While raw material costs and certain one-time expenses impacted gross profit margins, the company's 'funding-the-growth' initiatives and pricing strategies helped to mitigate these pressures.

Colgate-Palmolive Company reported a solid third quarter and nine-month period ending September 30, 2011, demonstrating robust sales growth driven by both volume and strategic acquisitions. Net sales for the quarter increased by 11.0% to $4,383 million, with a significant portion attributed to the acquisition of the Sanex personal care business and favorable foreign exchange rates. For the nine-month period, net sales grew 8.5% to $12,562 million. Profitability was impacted by several factors, including higher raw material costs which pressured gross margins, offset by cost-saving initiatives and pricing actions. Despite these pressures, operating profit increased for both the quarter and the nine-month period, reflecting effective cost management and the positive impact of strategic divestitures, such as the sale of laundry detergent brands in Colombia. Diluted earnings per share also saw an increase, highlighting the company's ability to translate sales growth into shareholder value, even amidst challenging global economic conditions and competitive pressures.

Colgate-Palmolive Company (CL) reported a strong second quarter and first half of 2011, demonstrating robust sales growth driven by both volume and pricing across its global operations. The company saw a significant increase in net sales, rising 9.5% for the quarter and 7% for the first half, fueled by a healthy 3% volume growth and positive foreign exchange impacts, particularly in Latin America and Greater Asia/Africa. Despite rising commodity costs impacting gross profit margins, Colgate-Palmolive effectively managed operating expenses, leading to an increase in operating profit for the quarter and a significant year-over-year improvement for the six-month period, largely due to the absence of a one-time charge from the prior year related to Venezuelan hyperinflationary accounting. A key strategic move during the quarter was the acquisition of the Sanex personal care business from Unilever for $960 million, aimed at strengthening Colgate's European personal care portfolio. This acquisition, financed through a combination of cash, asset sales, and commercial paper, is expected to be accretive to earnings. The company also continued its commitment to shareholder returns, increasing its annualized dividend and actively engaging in share repurchases. While facing challenges such as increased competition and rising commodity costs, Colgate-Palmolive remains focused on its strategic initiatives to drive brand engagement, innovation, and efficiency, positioning it for sustained long-term growth.

Colgate-Palmolive Company reported strong top-line growth in the first quarter of 2011, with a 4.5% increase in net sales to $3.994 billion, driven by a combination of volume growth (2.0%) and favorable foreign exchange impacts (3.0%). However, organic sales, which exclude these factors, grew at a more modest 1.5%, indicating some pricing pressure or a challenging sales environment in certain regions. Net income attributable to Colgate-Palmolive Company significantly increased to $576 million from $357 million in the prior year, boosted by the absence of a significant one-time charge related to Venezuela's hyperinflationary accounting in the prior year's first quarter. Excluding this charge, net income would have decreased by 8% year-over-year.

Colgate-Palmolive Company's (CL) third quarter 2010 results show a slight decrease in net sales year-over-year, primarily due to unfavorable foreign exchange rates, although organic sales showed positive growth. Diluted Earnings Per Share (EPS) saw an increase to $1.21 from $1.12 in the prior year's third quarter, indicating improved profitability on a per-share basis. For the nine-month period, Net Sales increased, driven by volume growth, but Diluted EPS decreased year-over-year. This decrease in nine-month EPS was significantly impacted by a one-time charge related to the transition to hyperinflationary accounting in Venezuela, which masked underlying operational improvements. Despite macro-economic challenges and foreign currency headwinds, the company demonstrated resilience through strong organic sales growth in key segments like Oral, Personal and Home Care. The company continues to invest in advertising and promotional activities, particularly in the Greater Asia/Africa region which showed robust sales growth. Shareholder returns were supported by an increased quarterly dividend and a new share repurchase program, signaling management's confidence in future performance and commitment to returning value to investors.

Colgate-Palmolive Company (CL) reported its financial results for the second quarter and first half of 2010. For the second quarter, net sales increased by 2.0% year-over-year to $3.814 billion, with organic sales growing 3.5%. Diluted earnings per share (EPS) rose to $1.17 from $1.07 in the prior year's second quarter. The company demonstrated strong operational performance in key segments, particularly in Greater Asia/Africa and North America. However, the first half of the year saw a decrease in net income and EPS due to a significant one-time charge related to hyperinflationary accounting in Venezuela, amounting to $271 million or $0.52 per share. Excluding this charge, the first-half performance showed a substantial improvement. The company's financial health remains robust, supported by strong operating cash flow. Strategic initiatives focused on innovation, consumer engagement, and cost efficiencies are driving growth across its core product categories. While facing challenges such as foreign currency fluctuations and the ongoing economic difficulties in Venezuela, Colgate-Palmolive is focused on its long-term strategy to enhance shareholder value through a diversified global presence and strong brand portfolio.

Colgate-Palmolive Co. (CL) reported its first-quarter 2010 financial results, showing a 9.5% increase in worldwide net sales to $3.83 billion compared to the prior year, driven by a 6.0% volume growth and a 3.5% positive foreign exchange impact. The company highlighted strong performance in its Oral, Personal and Home Care segment, which saw a 10.5% net sales increase, with robust volume growth across its geographic regions, particularly in Latin America and Asia/Africa. However, net income attributable to Colgate-Palmolive Company and diluted earnings per share declined to $357 million and $0.69, respectively, down from $508 million and $0.97 in the first quarter of 2009. This decline was significantly impacted by a one-time $271 million charge related to the transition to hyperinflationary accounting in Venezuela. Excluding the Venezuela-related charge, operating profit increased by 17% and net income attributable to Colgate-Palmolive Company rose by 24%, demonstrating the underlying strength of the company's core operations. The company also announced a 20% increase in its annualized common stock dividend to $2.03 per share and a new share repurchase program, signaling a commitment to returning value to shareholders. Despite the reported net income decrease, the company's strategic focus on innovation, cost efficiencies, and market leadership, coupled with broad geographic diversification, positions it to navigate challenging global economic conditions and continue long-term value creation.

Colgate-Palmolive Company (CL) reported solid financial results for the third quarter and the first nine months of 2009, demonstrating resilience in a challenging global economic environment. Net sales for the third quarter were flat year-over-year at $3.998 billion, with organic sales growing a robust 7.0%. Diluted Earnings Per Share (EPS) increased significantly to $1.12 for the quarter, up from $0.94 in the prior year, reflecting improved profitability and effective cost management. The company successfully navigated currency headwinds, particularly the Venezuelan situation, and benefited from lower commodity prices. The completion of the 2004 Restructuring Program is expected to provide ongoing cost savings and support future cash flows. Key drivers of performance included strong volume growth and pricing strategies across various geographic segments, particularly in North America and Latin America. While some regions faced foreign exchange challenges, the company's diversified global presence helped mitigate overall risk. Colgate-Palmolive also continued to return capital to shareholders through increased dividends and share repurchases. The company's focus on core categories, innovation, and operational efficiency positions it for continued performance in the face of persistent global macroeconomic uncertainty.

Colgate-Palmolive Co. (CL) reported its second-quarter and first-half results for 2009, demonstrating resilience in a challenging global economic environment. For the three months ended June 30, 2009, net sales were $3.75 billion, a decrease of 5.5% compared to the prior year, primarily due to volume declines and unfavorable foreign exchange impacts, although net selling price increases partially offset this. Diluted earnings per share (EPS) rose to $1.07, an increase from $0.92 in the prior year's second quarter, reflecting improved profitability and effective cost management. The company saw strong performance in North America and Latin America, with solid organic sales growth in these regions. Despite global headwinds, including currency fluctuations and challenging macroeconomic conditions, Colgate-Palmolive maintained its focus on operational efficiency and strategic initiatives to drive growth and shareholder value.